FemHealth Ventures β Full Portfolio
27 tracked investments Β· listed companies and verified rows first
Raydiant Oximetry is a clinical-stage medical device company developing Lumerah, a noninvasive fetal pulse oximeter that directly measures fetal oxygen levels using biophotonics and machine learning.
Digital HealthFemTechMedical DevicesSan Ramon, US
Michael Nagel(Chief Executive Officer)John Maroney(Director)Charles McDonald(Director)Neil P. Ray(Executive Officer, Director)
Co-investorsBand of AngelsSteelSky VenturesTri-Valley VenturesAvestria VenturesBill & Melinda Gates FoundationRhia Ventures+3 more
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsExSight VenturesSolasta VenturesAccess BiotechnologyBios PartnersCorrelation VenturesHatteras Venture Partners+2 more
10Beauty operates robotic manicure stations using single-use pod technology and proprietary nail-strengthening polishes.
ConsumerHealthtechRoboticsWestwood, US
Alex Shashou(Founder & CEO)Willie Litvack(Founder & General Partner)inSean Tolkin(Founder & General Partner)inAlexander Shashouin
Co-investorsAlumni VenturesBasecamp FundBlue Ivy VenturesCentre Street PartnersFormus CapitalGood Friends+8 more
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)
BoardSurbhi Sarna(Director)
Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+18 more
BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue.
BiotechHealthtechMedical DevicesNew Materials
Juliana Blum(CEO & Director)Billy Heim(COO)
Co-investorsHemi Ventures, LlcJoyance PartnersNew Orleans Startup FundThe Launch PlaceIndieBio
Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.
BiotechMedical Devices
Charles Sidoti(Founder)in
Co-investorsAngel Physicians FundExcelestar VenturesSchooner CapitalSV Health Investors
Cercle builds a platform that ingests and transforms healthcare data at scale into insights, with a focus on fertility and reproductive care.
AI & Machine LearningData & InfrastructureFemTechHealthtechSan Francisco, US
Andreas Melder(Co-founder & CEO)Dr. Irene Cuevas(Co-founder & Chief Scientist)Liya Sharif Lancia(Founder)Pran Punniamoorthy(CTO)Lucy Huang(COO)
Co-investorsOutsidersRogue Womens Fund
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(Executive Officer, Director)Janice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundLongwood Fund+2 more
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)James Leech(Executive Officer)Matthew E. Likens(Executive Officer, Director)
BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalGilde HealthcareMedical Technology Venture PartnersMedTech Venture Partners+2 more
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources, implanted during brain tumor removal surgery to deliver targeted radiation at the surgical site.
BiotechHealthtechMedical Devices
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health Capital
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionKaiser Permanente VenturesKluz VenturesLightstone Ventures+5 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsaMoonVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcJSD Capital, LLCUS Venture Partners
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Co-investorsKhosla VenturesAllerfund Ventures, LlcGlobal BrainMedical Incubator Japan K.K.ShangBay Capital LLCSBI Investment
Imperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey.
HealthtechMedical DevicesCampbell, US
Farhad Khosravi(Executive Officer, Director)Matthew Garrett(Executive Officer)Charles Alpuche(Executive Officer)Scott Elliott(Executive Officer)
BoardJames Rogers(Director)Stacy Enxing Seng(Director)
Co-investorsAscension VenturesDelos CapitalLightstone Ventures
inSoma Bio develops biomaterial products for reconstruction plastic surgery, enabling surgeons to use patients' own tissue instead of synthetic implants and fillers for breast and facial reconstruction procedures.
BiotechHealthtechMedical DevicesDurham, US
Stefan Roberts(Founder)inAshutosh Chilkoti(Founder)in
BoardScott Hollenbeck(Lead Medical Advisor)Juliana Blum(Director)Heather Brennan(Director)June S. Almenoff(Director)
Co-investorsDuke Capital PartnersY Combinator
Kanvas Bio operates a full-stack microbiome drug discovery platform, using a spatial mapping engine to image host-microbiome interactions and in-house manufacturing to produce live biotherapeutics.
BiotechDeep TechHealthtechMonmouth Junction, US
Matthew Cheng(Executive Officer, Director)Hao Shi(Executive Officer, Director)Iwijn De Vlaminck(Executive Officer, Director)
BoardJason Pontin(Director)inJustin Smithline(Director)in
Co-investorsBascom VenturesBoutique Venture PartnersDCVC (Data Collective)Germin8 VenturesKicker VenturesPangaea Ventures Us Inc.+2 more
Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.
Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US
Josh DeFonzo(Founder)inJason Wilson(Founder)
Co-investorsThreshold VenturesFounders FundLux CapitalAverin CapitalSonder CapitalMana Ventures+1 more
HealthtechNew Orleans, US
Mark Heiman(Executive Officer)Dale Pfost(Executive Officer, Director, Promoter)
BoardDon Marvin(Director)Richard Montgomery(Director)Ross Barrett(Director)John Elstrott(Director, Promoter)
Co-investorsSofinnova VenturesBayern KapitalDCVC (Data Collective)Pangaea Ventures
HealthtechDenver, US
Edward Likovich(Executive Officer, Director)James Cook(Executive Officer, Director, Promoter)
BoardThomas Virden(Director)Ben Wire(Director)inChris Saxman(Director)Rohit Seth(Director)
Co-investorsAllied Venture PartnersCobalt VenturesForefront VentureHealthtech CapitalRockies Venture ClubSocial Starts+2 more
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Kevin Caldwell(CEO, Co-Founder & President)inDr. Woods(Chief Science Officer, Co-Founder, EVP, CLIA Laboratory Director)Sebastian Giwa(Director)Erik Woods(Founder)in
BoardWilliam Trenchard(Director)inThomas Cycyota(Director)
Co-investorsHemisphere Ventures LLCManta Ray VenturesVivo CapitalXYZ Venture CapitalFirst Round CapitalVillage Global
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
BiotechFemTechHealthtechMedical DevicesBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Co-investorsAscension VenturesClavystBioDelos CapitalIyengar Capital PartnersAmed VenturesCatalyst Health Ventures
Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.
BiotechDigital HealthMental HealthMorristown, US
Sahil V. Kirpekar(President and CEO)Gregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in
Co-investorsMitsui Global InvestmentMPM BioImpactNovo Holdings
Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump.
Digital HealthHardwareHealthtechMedical DevicesManchester, US
Co-investorsGraph VenturesJavelin Venture PartnersLong Journey VenturesUlu Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.